Lundbeck
-
"24.1.2022 17.56 · MarketWire
Lundbeck: Migrænemiddel godkendt af EU-Kommissionen
(Opdateres)Lundbecks middel mod migræne, Vyepti, har fået grønt lys af EU-Kommissionen og bliver dermed godkendt til det europæiske marked.
Det meddeler Lundbeck mandag eftermiddag.
Godkendelsen kommer, efter at et ekspertpanel under de europæiske sundhedsmyndigheder, EMA, i november sidste år gav sin anbefaling af midlet.
.\˙ MarketWire
Christian Iversen Kielberg
"Hvad gør aktien? Den falder naturligvis...
Hvornår tager dette selskab sig sammen?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind